Form 4: Calumet Inc. Director Stephen P. Mawer Sells Shares Under 10b5-1 Trading Plan

Director Stephen P. Mawer sold 3,655 shares of Calumet Inc. common stock at an average price of $9.29 per share under a pre-arranged 10b5-1 trading plan.

Summary

• On April 22, 2025, Stephen P. Mawer, a director of Calumet Inc., sold 3,655 shares of common stock.
• The sale was executed at a weighted average price of $9.29 per share.
• The transactions occurred within a price range of $9.18 to $9.45 per share.
• The sale was conducted under a Rule 10b5-1 trading plan adopted on November 15, 2024.
• Following the transaction, Mawer directly owns 283,652 shares of Calumet Inc.
• The closing price of Calumet, Inc. common stock on the Nasdaq Global Select Market on November 15, 2024, was $20.92 per share.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by a director. It doesn't inherently convey positive or negative sentiment, but the sale itself could be interpreted in various ways by the market.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. The use of a 10b5-1 trading plan suggests the insider is selling shares in a pre-planned manner to avoid accusations of trading on inside information.

Stakeholder Impact

• Shareholders may react to the stock sale, although the use of a 10b5-1 plan suggests it was pre-planned.
• The impact on employees, customers, suppliers, and creditors is likely minimal.

Key Dates

Keywords

Calumet Inc., Stephen P. Mawer, Form 4, Stock Sale, Director, 10b5-1 Trading Plan, Insider Trading